As of 2024-12-12, the Relative Valuation of Titan Medical Inc (TMD.TO) is 0.97 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 0.80 CAD, the upside of Titan Medical Inc based on Relative Valuation is 21.2%.
The range of the Relative Valuation is (6.18) - 8.36 CAD.
| Range | Selected | |
| Trailing P/E multiples | 38.3x - 40.5x | 39.4x |
| Forward P/E multiples | 35.4x - 35.9x | 35.7x |
| Fair Price | (6.18) - 8.36 | 0.97 |
| Upside | -872.3% - 945.5% | 21.2% |
| Date | P/E |
| 2024-11-22 | -7.01 |
| 2024-11-21 | -7.36 |
| 2024-11-20 | -7.80 |
| 2024-11-19 | -7.54 |
| 2024-11-18 | -7.89 |
| 2024-11-15 | -7.89 |
| 2024-11-13 | -8.07 |
| 2024-11-12 | -8.15 |
| 2024-11-11 | -7.89 |
| 2024-11-08 | -8.86 |
| 2024-11-07 | -9.64 |
| 2024-11-06 | -9.64 |
| 2024-11-05 | -9.47 |
| 2024-11-04 | -9.64 |
| 2024-11-01 | -10.13 |
| 2024-10-31 | -10.17 |
| 2024-10-30 | -12.01 |
| 2024-10-29 | -13.15 |
| 2024-10-28 | -9.73 |
| 2024-10-25 | -10.00 |
| 2024-10-24 | -9.91 |
| 2024-10-23 | -9.82 |
| 2024-10-22 | -10.08 |
| 2024-10-21 | -10.08 |
| 2024-10-18 | -10.08 |
| 2024-10-17 | -10.52 |
| 2024-10-16 | -12.27 |
| 2024-10-15 | -9.86 |
| 2024-10-11 | -10.41 |
| 2024-10-10 | -9.86 |
| 2024-10-09 | -10.41 |
| 2024-10-07 | -10.96 |
| 2024-10-04 | -10.96 |
| 2024-10-03 | -10.96 |
| 2024-10-02 | -10.96 |
| 2024-10-01 | -12.06 |
| 2024-09-30 | -10.96 |
| 2024-09-27 | -12.06 |
| 2024-09-25 | -10.96 |
| 2024-09-24 | -12.06 |
| 2024-09-23 | -10.96 |
| 2024-09-20 | -12.06 |
| 2024-09-19 | -10.96 |
| 2024-09-18 | -10.96 |
| 2024-09-17 | -12.06 |
| 2024-09-16 | -12.06 |
| 2024-09-13 | -12.06 |
| 2024-09-12 | -10.96 |
| 2024-09-11 | -10.96 |